These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21962938)

  • 1. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
    Stewart JT
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancytopenia and valproic acid: a dose-related association.
    Oluboka OJ; Haslam D; Gardner DM
    J Am Geriatr Soc; 2000 Mar; 48(3):349-50. PubMed ID: 10733073
    [No Abstract]   [Full Text] [Related]  

  • 3. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare occurrence of isolated neutropenia with valproic acid: a case report.
    Chakraborty S; Chakraborty J; Mandal S; Ghosal MK
    J Indian Med Assoc; 2011 May; 109(5):345-6. PubMed ID: 22187773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of bipolar affective illnesses with valproate. A review of the literature].
    Retzow A; Emrich HM
    Psychiatr Prax; 1998 Jul; 25(4):163-71. PubMed ID: 9738242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of effectiveness of valproate in neuropsychiatry.
    Bowden CL
    Expert Rev Neurother; 2007 Jan; 7(1):9-16. PubMed ID: 17187491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate: do formulations matter?
    Citrome L
    J Clin Pharm Ther; 2008 Aug; 33(4):457; author reply 458. PubMed ID: 18613865
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Banuelos-Arzac C
    J Child Adolesc Psychiatr Nurs; 2008 May; 21(2):68. PubMed ID: 18429835
    [No Abstract]   [Full Text] [Related]  

  • 10. Algorithm for the treatment of rapid cycling.
    Yamada K
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S73-5. PubMed ID: 10560903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 12. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
    Wheeler A; Robinson G; Fraser A
    Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
    Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
    Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
    Longo LP
    Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
    [No Abstract]   [Full Text] [Related]  

  • 16. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L; Hall Y; Schubert D
    Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential risks associated with high-dose valproate in pregnancy in psychiatric patients.
    Vajda FJ; Solinas C
    Aust N Z J Psychiatry; 2005 Jun; 39(6):526-7. PubMed ID: 15943661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inappropriate antidiuretic hormone secretion induced by sodium valproate].
    Bève E; Beck E; Pinto E; Ansseau M
    Rev Med Liege; 2010 Jan; 65(1):6-9. PubMed ID: 20222501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
    Joffe H; Cohen LS; Suppes T; McLaughlin WL; Lavori P; Adams JM; Hwang CH; Hall JE; Sachs GS
    Biol Psychiatry; 2006 Jun; 59(11):1078-86. PubMed ID: 16448626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent valproic acid thrombocytopenia in bipolar disorder.
    Kaufman KR; Gerner R
    Ann Clin Psychiatry; 1998 Mar; 10(1):35-7. PubMed ID: 9622048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.